
A MULTICENTER, RANDOMIZED TRIAL OF SIMULECT® WITH EARLY NEORAL® VS. ATGAM® WITH DELAYED NEORAL® IN RENAL TRANSPLANTATION. A 6-MONTH INTERIM ANALYSIS.
Author(s) -
H W Sollinger,
B. Kaplan,
Mark D. Pescovitz,
Benjamin Philosophe,
Allan M. Roza,
Kenneth L. Brayman,
Kenneth A. Somberg
Publication year - 1999
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-199904150-00606
Subject(s) - medicine , basiliximab , transplantation , regimen , interim analysis , urology , tolerability , surgery , renal function , randomized controlled trial , kidney transplantation , adverse effect